A new study found that infants receiving maternal Respiratory Syncytial Virus (RSV) vaccination or Nirsevimab after birth had ...
Novartis today announced that the World Health Organization (WHO) has prequalified Coartem® (artemether-lumefantrine) Baby, the first and only antimalarial developed specifically for newborns and ...
Critical congenital heart diseases, or CCHDs, are a group of life-threatening structural heart defects present at birth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results